2026. Clinical outcomes and pathogenetic mechanisms of adjunctive ribonucleic acid therapy in adult patients with measles during the period of increased incidence in 2025–2026. Infectious Diseases – Infektsiyni khvoroby. 3 (Sep. 2026), 13–26. DOI:https://doi.org/10.11603/1681-2727.2026.3.16753.